Andrew Cheng - Net Worth and Insider Trading

Andrew Cheng Net Worth

The estimated net worth of Andrew Cheng is at least $19 Million dollars as of 2024-11-05. Andrew Cheng is the President and CEO of Akero Therapeutics Inc and owns about 605,417 shares of Akero Therapeutics Inc (AKRO) stock worth over $19 Million. Details can be seen in Andrew Cheng's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andrew Cheng has not made any transactions after 2024-11-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Andrew Cheng

To

Andrew Cheng Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Andrew Cheng owns 3 companies in total, including Arbutus Biopharma Corp (ABUS) , Akero Therapeutics Inc (AKRO) , and Vera Therapeutics Inc (VERA) .

Click here to see the complete history of Andrew Cheng’s form 4 insider trades.

Insider Ownership Summary of Andrew Cheng

Ticker Comapny Transaction Date Type of Owner
ABUS Arbutus Biopharma Corp 2019-08-17 director
AKRO Akero Therapeutics Inc 2024-10-18 director & President & CEO
VERA Vera Therapeutics Inc 2021-05-13 director

Andrew Cheng Latest Holdings Summary

Andrew Cheng currently owns a total of 1 stock. Andrew Cheng owns 605,417 shares of Akero Therapeutics Inc (AKRO) as of November 1, 2024, with a value of $19 Million.

Latest Holdings of Andrew Cheng

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AKRO Akero Therapeutics Inc 2024-11-01 605,417 31.60 19,131,177

Holding Weightings of Andrew Cheng


Andrew Cheng Form 4 Trading Tracker

According to the SEC Form 4 filings, Andrew Cheng has made a total of 30 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 30 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 108,366 shares on November 1, 2024, which brought Andrew Cheng around $3 Million.

Insider Trading History of Andrew Cheng

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Andrew Cheng Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Andrew Cheng Ownership Network

Ownership Network List of Andrew Cheng

No Data

Ownership Network Relation of Andrew Cheng

Insider Network Chart

Andrew Cheng Owned Company Details

What does Arbutus Biopharma Corp do?

Who are the key executives at Arbutus Biopharma Corp?

Andrew Cheng is the director of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .

Arbutus Biopharma Corp (ABUS) Insider Trades Summary

Over the past 18 months, Andrew Cheng made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .

In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.

Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arbutus Biopharma Corp Insider Transactions

No Available Data

Andrew Cheng Mailing Address

Above is the net worth, insider trading, and ownership report for Andrew Cheng. You might contact Andrew Cheng via mailing address: 170 Harbor Way, 3rd Floor, C/o Akero Therapeutics, Inc., South San Francisco Ca 94080.